Qing Wang

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: BLOOD ADVANCES. 2023;7(9):1929-1943
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
Naeem A; Utro F; Wang Q; Cha J; Vihinen M; Martindale S; Zhou Y; Ren Y; Tyekucheva S; Kim AS; Fernandes SM; Saksena G; Rhrissorrakrai K; Levovitz C; Danysh BP; Slowik K; Jacobs RA; Davids MS; Lederer JA; Zain R; Smith CIE; Leshchiner I; Parida L; Getz G; Brown JR
Article: LEUKEMIA. 2021;35(5):1317-1329
BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib
Estupinan HY; Wang Q; Berglof A; Schaafsma GCP; Shi Y; Zhou L; Mohammad DK; Yu L; Vihinen M; Zain R; Smith CIE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2018;183(2):212-224
Ibrutinib induces rapid down-regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia-related genes in blood and lymph nodes
Palma M; Krstic A; Perez LP; Bergloef A; Meinke S; Wang Q; Blomberg KEM; Kamali-Moghaddam M; Shen Q; Jaremko G; Lundin J; De Paepe A; Hoeglund P; Kimby E; OEsterborg A; Mansson R; Smith CIE
Article: BMC PEDIATRICS. 2018;18(1):285
Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report
Lundin KE; Wang Q; Hamasy A; Marits P; Uzunel M; Wirta V; Wikstrom A-C; Fasth A; Ekwall O; Smith CIE
Article: LEUKEMIA. 2017;31(1):177-185
Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant
Hamasy A; Wang Q; Blomberg KEM; Mohammad DK; Yu L; Vihinen M; Berglof A; Smith CIE
Article: PLOS ONE. 2017;12(4):e0174909
ANKRD54 preferentially selects Bruton's Tyrosine Kinase (BTK) from a Human Src-Homology 3 (SH3) domain library
Gustafsson MO; Mohammad' DK; Ylosmaki E; Choi H; Shrestha S; Wang Q; Nore BF; Saksela K; Smith CIE
Article: PLOS ONE. 2013;8(7):e69784
Histone demethylase retinoblastoma binding protein 2 is overexpressed in hepatocellular carcinoma and negatively regulated by hsa-miR-212.
Liang X; Zeng J; Wang L; Fang M; Wang Q; Zhao M; Xu X; Liu Z; Li W; Liu S; Yu H; Jia J; Chen C

Alla övriga publikationer

Thesis / dissertation: 2020
Bruton tyrosine kinase in immunodeficiency and in B-cell malignancy
Wang, Qing
Review: CURRENT ALLERGY AND ASTHMA REPORTS. 2015;15(3):510
Splice-Correction Strategies for Treatment of X-Linked Agammaglobulinemia
Bestas B; Turunen JJ; Blomberg KEM; Wang Q; Mansson R; Andaloussi SEL; Berglof A; Smith CIE

Anställningar

Anknuten till Forskning, Laboratoriemedicin, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för laboratoriemedicin, Karolinska Institutet, 2020

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI